Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma's First Reboost Vacc-4x Study Accepted for Publication in the Vaccine Journal

Bionor Pharma ASA (OSE: BIONOR) announces that the results from the Company’s first re-boost clinical trial of Vacc-4x have been accepted for publication in the renowned journal Vaccine. 

The Phase II trial was conducted at Oslo University Hospital and completed in 2010. The trial investigated the effect of re-boosting 22 available patients from previous study with the Company’s leading therapeutic HIV vaccine candidate Vacc-4x.  The study demonstrated that it is possible to elicit strong memory immune responses up to 7 years after the initial vaccination. 

 

 

If you would like to read more, visit Bionor Pharam's website here.

Associated companies:


Related news

Latest news

Bjørøya AS expands its fleet

The Namdal coastline offers optimal conditions for Atlantic Salmon,

DNV GL’s Energy Transition Outlook predicts continuing demand growth for Middle East and North Africa oil and gas

Among its forecasts for 10 global regions,

Dana Olson joins DNV GL as Global Solar Segment Leader

As identified in DNV GL’s 2018 Energy Transition Outlook,

Invitation to Elkem’s Capital Markets Day 2018

Global changes and current megatrends are driving the need for new solutions.

DNV GL successfully completed technical due diligence for 25 MW Windfloat Atlantic floating wind project

The project is the first project-financed floating wind farm.

DNV GL launches first Battery Performance Scorecard to provide independent data to battery system buyers

The release comes as increased electrification is beginning to disrupt everyday markets, 

New Floor Tilt Model - Series X MVD

Tilt Controls, LED Backlight Technology Optical Bonding Technology, MultiTouch Optional integrated HT C02 computer.

A sustainability dive into the future of the ocean and the industries that rely on it

DNV GL has been entrusted with producing the two first reports;

TechnipFMC Signs a Major Contract with MIDOR for Their Refinery Expansion and Modernization in Egypt

Starting in 2022, the modernized complex will exclusively produce Euro V products,